Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Bulletin of the Veterinary Institute in Pulawy

The Journal of National Veterinary Research Institute in Pulawy

4 Issues per year


IMPACT FACTOR 2016: 0.462

SCImago Journal Rank (SJR) 2016: 0.235
Source Normalized Impact per Paper (SNIP) 2016: 0.364

Open Access
Online
ISSN
2300-3235
See all formats and pricing
More options …

Analytical Procedure for the Determination of Tulathromycin in Swine Plasma

Anna Gajda
  • Corresponding author
  • Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Andrzej Posyniak
  • Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Tomasz Błądek
  • Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-06-21 | DOI: https://doi.org/10.2478/bvip-2013-0035

Abstract

For the measurement of tulathromycin distribution in swine plasma an accurate and reliable analytical method was developed. The extraction was performed with oxalic acid buffer (pH=4.0). Plasma samples were cleaned up by solid phase extraction procedure using polymeric cartriges. Chromatographic separation was achieved on a C 18 analytical column using mobile phase consisting of acetonitrile, 0.1% formic acid in gradient mode. Detection was carried out by liquid chromatography tandem mass spectrometry. Azithromycin was used as internal standard. The method has been successfully validated. The recovery from spiked samples ranged from 94% to 110%. The limit of detection was 2 ng/mL and the limit of quantification was 5 ng/mL. The method was developed to investigate the pharmacokinetics of tulathromycin in swine plasma. Applicability of the method was tested with plasma from swine administered with a single dose of tulathromycin.

Keywords : swine; tulathromycin; plasma; validation

  • 1. Anon. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine: Guidance for Industry, Bioanalytical Method Validation, 2001.Google Scholar

  • 2. Anon. European Medicines Agency (EMEA): Guideline on bioanalytical method validation, 2011.Google Scholar

  • 3. Benchaoui H.A., Nowakowski M., Sherington J., Rowan T.G., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Therap 2004, 27, 203-210.Google Scholar

  • 4. Bohm D.A., Stachel C.S., Gowik P.: Multi-method for the determination of antibiotics of different substance groups in milk and validation in accordance with Commission Decision 2002/657/EC. J Chromatogr A 2009, 1216, 8217-8223.Web of ScienceGoogle Scholar

  • 5. Boner P.L., Gottschall D.W., Kim-Kang H.: Determination and confirmation of tulathromycin residues in bovine liver and porcine kidney via their common hydrolytic fragment using high-performance liquid chromatography/tandem mass spectrometry. J AOAC Int 2011, 94, 436-445.PubMedGoogle Scholar

  • 6. Charles L., Segreti J.: Choosing the right macrolide antibiotic. A guide to selection. Drugs 1997, 53, 349-357.Google Scholar

  • 7. Darrington R.T., Zhang L., Ji Q., Rafka R.J., Morton B.J.: Equilibrium, kinetics, and mechanism of acyl migration in tulathromycin, a novel triamilide antibiotic. AAPS Pharm Sci 2003, 5 , 1187-1189.Google Scholar

  • 8. Galer D., Hessong S., Beato B., Risk J., Inskeep P., Weerasinghe C., Schneider R., Langer C., LaPerle J., Renouf D., Bessire A., Español E., Rafka R., Ragan C., Boettner W., Murphy T., Keller D., Benchaoui H., Nowakowski M.: An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung. J Agric Food Chem 2004, 52, 2179-2191.Google Scholar

  • 9. Martos P.A., Lehotay S.J., Shurmer B: Ultratrace analysis of nine macrolides, including tulathromycin A (Draxxin), in edible animal tissues with minicolumn liquid chromatography tandem mass spectrometry. J Agric Food Chem 2008, 56, 8844-8850.Web of ScienceGoogle Scholar

  • 10. Nowakowski M.A., Inskeep P.B., Risk J.E., Skogerboe T.L., Benchaoui H.A., Meinert T.R., Sherington J., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic in cattle. Vet Therap 2004, 5, 60-74.Google Scholar

  • 11. Nutsch R.G., Hart F.J., Rooney K.A., Weigel D.J., Kilgore W.R., Skogerboe T.L.: Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease. Vet Therapeutics: Res Appl Vet Med 2005, 6, 214-224.Google Scholar

  • 12. Scheuch E., Spieker J., Venner M., Siegmund W.: Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry. J Chromatogr B 2007, 850, 464-470.Google Scholar

  • 13. Wang X., Tao Y.F., Huang L.L., Chen D.M., Yin S.Z., Ihsan A., Zhou W., Su S.J., Liu Z.L., Pan Y.H., Yuan Z.H.: Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. J Vet Pharmacol Therap 2012, 35, 282-289.Google Scholar

  • 14. Young G., Smith G.W., Leavens T.L., Wetzlich S.E., Baynes R.E., Mason S.E., Riviere J.E., Tell L.A.: Pharmacokinetics of tulathromycin following subcutaneous administration in meat goats. Res Vet Sci 2011, 90, 477-479.CrossrefGoogle Scholar

  • 15. Zhanel G.G., Dueck M., Hoban D.J., Vercaigne L.M., Embil J.M., Gin A.S., Karlowski J.A.: Review of macrolides and ketolides - focus on respiratory tract infections. Drugs 2001, 61, 443-498.CrossrefGoogle Scholar

About the article

Published Online: 2013-06-21

Published in Print: 2013-06-01


Citation Information: Bulletin of the Veterinary Institute in Pulawy, ISSN (Print) 0042-4870, DOI: https://doi.org/10.2478/bvip-2013-0035.

Export Citation

This content is open access.

Comments (0)

Please log in or register to comment.
Log in